Health Trials

Haemophilus Influenzae Type b

1

Review clinical trials related to Haemophilus Influenzae Type b. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series

The purpose of this study is to evaluate immunogenicity, safety and lot-to-lot consistency of LBVD in comparison to co-administration of Pentavalent vaccine and Poliomyelitis Vaccine (Inactivated) in separate injections at four weeks after completion of three-dose primary series at 6-10-14 weeks of age when administered to healthy infants

Participants needed: 1,186
Trial details
Phase: Phase 2, Phase 3Age: 6-8Biological sex: AllType: InterventionalSponsor: LG ChemUpdated: Jul 3, 2025Locations: 1
Eligibility criteria

healthy infants from 6 weeks to 8 weeks of age (both inclusive) [+3]

Known history of Hib infection, HepB, diphtheria, tetanus, pertussis, or poliomy... [+10]

Read more